BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $739 | +9.5% | 104,315 | +8.8% | 0.00% | – |
| Q2 2023 | $675 | -7.4% | 95,842 | +9.7% | 0.00% | – |
| Q1 2023 | $729 | -24.2% | 87,328 | +4.2% | 0.00% | – |
| Q4 2022 | $962 | -99.9% | 83,824 | +2.6% | 0.00% | – |
| Q3 2022 | $1,030,000 | +27.8% | 81,719 | +7.3% | 0.00% | – |
| Q2 2022 | $806,000 | -38.8% | 76,146 | -6.0% | 0.00% | – |
| Q1 2022 | $1,317,000 | +8.2% | 81,009 | -7.8% | 0.00% | – |
| Q4 2021 | $1,217,000 | -9.8% | 87,845 | -6.4% | 0.00% | – |
| Q3 2021 | $1,349,000 | -7.4% | 93,857 | +1.8% | 0.00% | – |
| Q2 2021 | $1,457,000 | +49.3% | 92,166 | -4.0% | 0.00% | – |
| Q1 2021 | $976,000 | +49.9% | 95,990 | +9.9% | 0.00% | – |
| Q4 2020 | $651,000 | +438.0% | 87,345 | +148.7% | 0.00% | – |
| Q3 2020 | $121,000 | +128.3% | 35,115 | +216.1% | 0.00% | – |
| Q2 2020 | $53,000 | +152.4% | 11,110 | +7.9% | 0.00% | – |
| Q1 2020 | $21,000 | -53.3% | 10,294 | -20.4% | 0.00% | – |
| Q4 2019 | $45,000 | -69.2% | 12,929 | -53.7% | 0.00% | – |
| Q3 2017 | $146,000 | -98.1% | 27,923 | -96.3% | 0.00% | -100.0% |
| Q4 2015 | $7,741,000 | -38.7% | 750,100 | -32.2% | 0.00% | -33.3% |
| Q3 2015 | $12,621,000 | +7457.5% | 1,107,089 | +6399.7% | 0.00% | – |
| Q3 2014 | $167,000 | -99.0% | 17,033 | -98.9% | 0.00% | -100.0% |
| Q1 2014 | $16,748,000 | – | 1,583,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |